Sio Gene Therapies Inc. Earnings Per Share (Diluted)
Sio Gene Therapies Inc. reported Earnings Per Share (Diluted) of -$0.05 per share for the 3-month period ending 2022-12-31, per its 10-Q filed 2023-02-14.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2023-02-14
- Sio Gene Therapies Inc. earnings per share, diluted for the quarter ending 2022-12-31 was -$0.05.
- Sio Gene Therapies Inc. earnings per share, diluted for the quarter ending 2022-09-30 was -$0.04.
- Sio Gene Therapies Inc. earnings per share, diluted for the quarter ending 2022-06-30 was -$0.11.
- Sio Gene Therapies Inc. earnings per share, diluted for the quarter ending 2022-03-31 was -$0.18.
- Sio Gene Therapies Inc. earnings per share, diluted for fiscal 2022 was -$0.98.
- Sio Gene Therapies Inc. earnings per share, diluted for fiscal 2021 was -$0.62.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 12 month |
|---|---|---|---|---|
| 2022-12-31 | -$0.05 10-Q · filed 2023-02-14 | -$0.10 derived: net income ÷ weighted average shares · filed 2023-02-14 | -$0.21 10-Q · filed 2023-02-14 | -$0.39 derived: net income ÷ weighted average shares · filed 2023-02-14 |
| 2022-09-30 | -$0.04 10-Q · filed 2022-11-10 | -$0.16 10-Q · filed 2022-11-10 | -$0.34 derived: net income ÷ weighted average shares · filed 2023-02-14 | -$0.68 derived: net income ÷ weighted average shares · filed 2023-02-14 |
| 2022-06-30 | -$0.11 10-Q · filed 2022-08-11 | -$0.29 derived: net income ÷ weighted average shares · filed 2023-02-14 | -$0.64 derived: net income ÷ weighted average shares · filed 2023-02-14 | -$0.93 derived: net income ÷ weighted average shares · filed 2023-02-14 |
| 2022-03-31 | -$0.18 10-K · filed 2022-06-14 | -$0.53 derived: net income ÷ weighted average shares · filed 2023-02-14 | -$0.82 derived: net income ÷ weighted average shares · filed 2023-02-14 | -$0.98 10-K · filed 2022-06-14 |
| 2021-12-31 | -$0.35 10-Q · filed 2023-02-14 | -$0.64 derived: net income ÷ weighted average shares · filed 2023-02-14 | -$0.80 10-Q · filed 2023-02-14 | -$0.87 derived: net income ÷ weighted average shares · filed 2023-02-14 |
| 2021-09-30 | -$0.29 10-Q · filed 2022-11-10 | -$0.45 10-Q · filed 2022-11-10 | -$0.52 derived: net income ÷ weighted average shares · filed 2023-02-14 | -$0.71 derived: net income ÷ weighted average shares · filed 2023-02-14 |
| 2021-06-30 | -$0.16 10-Q · filed 2022-08-11 | -$0.22 derived: net income ÷ weighted average shares · filed 2023-02-14 | -$0.40 derived: net income ÷ weighted average shares · filed 2023-02-14 | -$0.60 derived: net income ÷ weighted average shares · filed 2023-02-14 |
| 2021-03-31 | -$0.05 10-K · filed 2022-06-14 | -$0.23 derived: net income ÷ weighted average shares · filed 2022-06-14 | -$0.43 derived: net income ÷ weighted average shares · filed 2022-06-14 | -$0.62 10-K · filed 2022-06-14 |
| 2020-12-31 | -$0.20 10-K · filed 2022-06-14 | -$0.41 derived: net income ÷ weighted average shares · filed 2022-06-14 | -$0.61 10-Q · filed 2022-02-11 | |
| 2020-09-30 | -$0.21 10-K · filed 2022-06-14 | -$0.41 10-Q · filed 2021-11-12 | ||
| 2020-06-30 | -$0.20 10-K · filed 2022-06-14 |